Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Biopsy Forceps

K-Number: K252722 · 2025-09-30

Decision Date2025-09-30
Product CodeDWZ
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Biopsy Forceps is a medical device manufactured by Fehling Instruments GmbH. It received FDA 510(k) clearance on 2025-09-30 under approval number K252722. The device is classified under product code DWZ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Biopsy Forceps?

Biopsy Forceps is a medical device that received FDA 510(k) clearance on 2025-09-30. It is manufactured by Fehling Instruments GmbH. The 510(k) number is K252722.

When was Biopsy Forceps approved by the FDA?

Biopsy Forceps received FDA 510(k) clearance on 2025-09-30, under approval number K252722.

What company makes Biopsy Forceps?

Biopsy Forceps is manufactured by Fehling Instruments GmbH.

What is the FDA product code for Biopsy Forceps?

The FDA product code for Biopsy Forceps is DWZ.

Related Clinical Trials

Related Devices (Code: DWZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.